We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Infectious disease screening in patients prior to undergoing immunosuppressive therapy.
- Authors
Sullivan, Richard; Gaskell, Catriona; Lewis, Craig R.; Vollmer‐Conna, Ute; Post, Jeffrey J.; Sullivan, R; Gaskell, C; R Lewis, C; Vollmer-Conna, U; Post, J J; Vollmer-Conna, Ute
- Abstract
Immunosuppression can reactivate quiescent infection or worsen the clinical effects of infection. Mortality due to Hepatitis B (HBV) reactivation is as high as 52%, while acute hepatic flares occur in up to 11% of cancer patients with Hepatitis C (HCV) who receive chemotherapy. Cancer specific mortality is higher in HIV infected patients in certain malignancies and immunosuppression can result in prolonged CD4 suppression. The development of Strongyloides stercoralis hyperinfection syndrome has also been reported in immunosuppressed cancer patients. This article is protected by copyright. All rights reserved.
- Publication
International Journal of Clinical Practice, 2019, Vol 73, Issue 10, pN.PAG
- ISSN
1368-5031
- Publication type
letter
- DOI
10.1111/ijcp.13406